Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c oxidase subunit 4 isoform 2 (COX4I2) is a nuclear-encoded structural subunit of complex IV (cytochrome c oxidase) in the mitochondrial electron transport chain[1][2]. It functions as a regulator of oxidative phosphorylation, facilitating electron transfer from cytochrome c to oxygen—the terminal step in ATP generation. The two isoforms of subunit IV, COX4I1 and COX4I2, enable tissue-specific and oxygen level-dependent optimization of mitochondrial respiration; COX4I2 is upregulated under low oxygen conditions (hypoxia), especially in placenta and lung tissues, and contributes to the adaptation of cellular energy metabolism[1][3]. Mutations in COX4I2 are associated with rare syndromic diseases affecting the exocrine pancreas, blood cells, and bone formation[2]. No drugs directly and specifically target COX4I2, but the entire cytochrome c oxidase complex is affected by certain poisons and metabolic inhibitors[1][2]. COX4I2 expression levels may offer potential as a biomarker for hypoxia adaptation and studies suggest a role in regulating reactive oxygen species (ROS) production under basal and hypoxic conditions[3]. Safety concerns with therapeutic targeting involve the risk of mitochondrial activity disruption, broad energetic consequences, and systemic toxicity.
Inhibition of electron transfer (for cytochrome c oxidase inhibitors); Modulation of oxygen sensing through altered subunit composition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase subunit 4 isoform 2, mitochondrial (COX4I2).